Brisk M&A in domestic pharmaceutical industry

Stimulated by the current consensus that domestic pharmaceutical industry is one of the high value-added industries and growing concern on the biotechnology field, the M&A fever are pronouncing among pharmaceuticals firms and financial investment companies.

KT&G is seeking to advance into the biotechnology sector and will decide to acquire Yungjin Pharm after its investigation team's final e...